跳转至内容
Merck
  • Design of the Lifestyle Improvement through Food and Exercise (LIFE) study: a randomized controlled trial of self-management of type 2 diabetes among African American patients from safety net health centers.

Design of the Lifestyle Improvement through Food and Exercise (LIFE) study: a randomized controlled trial of self-management of type 2 diabetes among African American patients from safety net health centers.

Contemporary clinical trials (2014-09-24)
Elizabeth B Lynch, Rebecca Liebman, Jennifer Ventrelle, Kathryn Keim, Bradley M Appelhans, Elizabeth F Avery, Bettina Tahsin, Hong Li, Merle Shapera, Leon Fogelfeld
摘要

The Lifestyle Improvement through Food and Exercise (LIFE) study is a community-based randomized-controlled trial to measure the effectiveness of a lifestyle intervention to improve glycemic control among African Americans with type 2 diabetes attending safety net clinics. The study enrolled African American adults with a diagnosis of type 2 diabetes and HbA1c ≥ 7.0 who had attended specific safety net community clinics in the prior year. 210 patients will be enrolled and randomized to either the LIFE intervention or a standard of care control group, which consists of two dietitian-led diabetes self-management classes. The LIFE intervention was delivered in 28 group sessions over 12 months and focused on improving diet through dietitian-led culturally-tailored nutrition education, increasing physical activity through self-monitoring using an accelerometer, increasing ability to manage blood sugar through modifications to lifestyle, and providing social support for behavior change. In addition to the group sessions, peer supporters made regular telephone calls to participants to monitor progress toward behavioral goals and provide social support. The 12-month intervention phase was followed by a six-month maintenance phase consisting of two group sessions. The primary outcome of the study is change in A1C from baseline to 12 months, and an additional follow-up will occur at 18 months. The hypothesis of the study is that the participants in the LIFE intervention will show a greater improvement in glycemic control over 12 months than participants in the control group.

材料
货号
品牌
产品描述

Sigma-Aldrich
胆固醇, Sigma Grade, ≥99%
Sigma-Aldrich
胆固醇, powder, BioReagent, suitable for cell culture, ≥99%
Sigma-Aldrich
胆固醇, from sheep wool, ≥92.5% (GC), powder
Sigma-Aldrich
SyntheChol ® NS0 补充, 500 ×, synthetic cholesterol, animal component-free, aqueous solution, sterile-filtered, suitable for cell culture
SAFC
胆固醇、植物的, SyntheChol®
Supelco
胆固醇 溶液, certified reference material, 10 mg/mL in chloroform
Sigma-Aldrich
肌酸酐, anhydrous, ≥98%
Supelco
胆固醇, Pharmaceutical Secondary Standard; Certified Reference Material
SAFC
胆固醇, from sheep wool, Controlled origin, meets USP/NF testing specifications
Supelco
肌酐, Pharmaceutical Secondary Standard; Certified Reference Material
Sigma-Aldrich
胆固醇, tested according to Ph. Eur.